Astec Lifesciences Ltd

Astec Lifescienc Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Astec Lifesciences Ltd

₹ 1,080 -0.16%
20 Dec - close price
astecls.com BSE: 533138 NSE: ASTEC
About

The Company is into manufacturing of agrochemical active ingredients (technical), bulk and formulations, intermediate products and it sells its products in India as well as exports them to approximately 24 countries.
Astec also has undertaken a number of custom synthesis projects, for its clients in Europe, Japan and the US. It is present only in business to business sale (B2B).[1] [2] [3]

Key Points

Product Portfolio
The company offers a range of products and intermediates, including fungicides, insecticides, herbicides, and various chemical compounds, serving global customers and including triazole fungicides, heterocyclic herbicides, sulfonylurea herbicides, synthetic pyrethroids, fluorinated compounds, halides, intermediates, ketones, ethers, alcohols, and many others. [1]

Website BSE NSE
  • Market Cap ₹ 2,118 Cr.
  • Current Price ₹ 1,080
  • High / Low ₹ 1,488 / 825
  • Stock P/E
  • Book Value ₹ 149
  • Dividend Yield 0.00 %
  • ROCE -4.48 %
  • ROE -11.9 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Stock is trading at 7.27 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 1.24% over past five years.
  • Company has a low return on equity of 5.97% over last 3 years.
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian

Part of BSE SmallCap BSE Allcap BSE Commodities

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
103 173 272 184 200 117 127 143 111 51 154 69 99
81 130 207 159 166 105 122 140 114 69 141 116 118
Operating Profit 21 43 65 25 33 12 5 3 -3 -18 13 -46 -20
OPM % 21% 25% 24% 14% 17% 10% 4% 2% -3% -36% 8% -67% -20%
1 2 7 3 4 4 3 2 1 1 2 1 2
Interest 2 3 3 4 5 6 6 6 6 6 7 7 9
Depreciation 8 9 11 9 8 9 8 9 9 9 9 9 11
Profit before tax 12 33 58 15 25 1 -6 -11 -18 -32 -1 -62 -39
Tax % 26% 25% 26% 25% 25% 31% -20% -26% -24% -24% 4% -36% 0%
9 25 43 11 18 1 -5 -8 -13 -24 -1 -40 -39
EPS in Rs 4.63 12.63 21.97 5.82 9.34 0.43 -2.54 -4.18 -6.85 -12.41 -0.49 -20.25 -19.66
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
174 207 267 233 299 368 431 523 555 677 628 458 372
146 171 213 201 236 299 354 437 443 522 551 464 444
Operating Profit 28 35 54 32 63 69 76 85 112 154 77 -6 -72
OPM % 16% 17% 20% 14% 21% 19% 18% 16% 20% 23% 12% -1% -19%
0 -0 -16 4 -8 12 11 12 8 10 13 6 6
Interest 7 9 13 13 12 11 12 13 5 9 21 25 29
Depreciation 12 15 13 10 14 15 19 23 26 34 34 36 38
Profit before tax 9 11 13 12 29 56 56 61 89 121 35 -62 -133
Tax % 32% 22% -17% 59% 33% 37% 36% 23% 27% 26% 27% -24%
6 9 15 5 19 35 36 48 65 90 26 -47 -104
EPS in Rs 3.30 4.68 7.60 2.55 9.80 17.87 18.28 24.28 33.21 45.85 13.04 -23.93 -52.81
Dividend Payout % 23% 21% 16% 0% 15% 8% 8% 6% 5% 3% 12% -6%
Compounded Sales Growth
10 Years: 8%
5 Years: 1%
3 Years: -6%
TTM: -25%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -302%
Stock Price CAGR
10 Years: 27%
5 Years: 21%
3 Years: -10%
1 Year: -3%
Return on Equity
10 Years: 13%
5 Years: 11%
3 Years: 6%
Last Year: -12%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 18 19 19 19 20 20 20 20 20 20 20 20 20
Reserves 88 95 116 99 119 150 183 227 290 377 400 350 272
73 83 93 127 127 125 176 99 187 279 341 494 500
82 88 133 85 69 119 83 226 181 221 219 112 90
Total Liabilities 261 284 362 330 334 413 461 572 678 897 979 975 882
121 132 133 95 103 115 167 194 213 340 318 386 539
CWIP 13 6 12 20 8 42 19 24 116 23 127 165 2
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
127 146 216 215 223 256 275 354 349 534 534 424 341
Total Assets 261 284 362 330 334 413 461 572 678 897 979 975 882

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
16 15 7 -13 19 65 15 168 -8 24 75 10
-13 -19 -19 -17 -18 -49 -52 -74 -73 -104 -113 -135
-2 3 12 31 -1 -18 37 -95 81 80 38 125
Net Cash Flow 1 -1 -0 2 1 -3 -0 0 0 0 -0 0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 131 91 142 126 135 122 103 112 123 148 90 135
Inventory Days 145 192 147 177 133 122 121 131 113 176 268 224
Days Payable 132 114 179 169 116 155 83 218 137 179 161 102
Cash Conversion Cycle 145 168 109 134 152 89 142 25 100 145 197 256
Working Capital Days 122 125 125 142 154 115 147 77 101 163 175 234
ROCE % 9% 11% 20% 12% 20% 22% 20% 20% 22% 22% 8% -4%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
65.19% 65.29% 65.29% 66.77% 66.76% 66.76% 66.76% 66.75% 66.75% 66.75% 66.75% 66.74%
0.29% 0.32% 0.48% 1.53% 2.19% 2.29% 1.95% 1.33% 1.28% 1.25% 1.03% 0.53%
12.74% 12.56% 11.79% 9.82% 9.57% 10.58% 10.15% 10.16% 9.74% 7.88% 3.37% 4.50%
21.78% 21.83% 22.45% 21.87% 21.49% 20.37% 21.13% 21.74% 22.22% 24.12% 28.85% 28.20%
No. of Shareholders 19,00216,95117,43317,63219,54517,80918,70318,72219,24419,84819,95519,727

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls